FCBT
AGRX

First Citizens Bank & Trust’s Agile Therapeutics AGRX Stock Holding History

First Citizens Bank & Trust’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$42K – 463
2022
Q1 		$42K Buy
+100
New +$63.8K ﹤0.01% 420

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Citizens Bank & Trust's AGRX Position: Q2 2022 in Review

First Citizens Bank & Trust sold out of Agile Therapeutics (AGRX) in Q2 2022, closing a stake of 100 shares — an estimated $42K sold.

First Citizens Bank & Trust first reported a position in AGRX in Q1 2022 and held it in 1 quarter. The position peaked at $42K in Q1 2022. 19 funds tracked by Wall St. Rank hold AGRX as of Q2 2022.

  • First Citizens Bank & Trust reported no remaining Agile Therapeutics position as of Q2 2022 after selling out during the quarter.
  • First Citizens Bank & Trust sold 100 Agile Therapeutics shares in Q2 2022, an estimated $42K.
  • First Citizens Bank & Trust first reported a position in Agile Therapeutics in Q1 2022 and held it in 1 quarter.
  • First Citizens Bank & Trust's Agile Therapeutics position peaked at $42K in Q1 2022.
  • 19 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2022.

Based on First Citizens Bank & Trust's 13F filing for Q2 2022, filed 26 Jul 2022.